Literature DB >> 34634682

Transdermal auricular vagus stimulation for the treatment of postural tachycardia syndrome.

André Diedrich1, Vasile Urechie2, Dana Shiffer3, Stefano Rigo4, Maura Minonzio3, Beatrice Cairo5, Emily C Smith2, Luis E Okamoto2, Franca Barbic6, Andrea Bisoglio4, Alberto Porta5, Italo Biaggioni2, Raffaello Furlan6.   

Abstract

Postural Tachycardia Syndrome (POTS) is a chronic disorder characterized by symptoms of orthostatic intolerance such as fatigue, lightheadedness, dizziness, palpitations, dyspnea, chest discomfort and remarkable tachycardia upon standing. Non-invasive transdermal vagal stimulators have been applied for the treatment of epilepsy, anxiety, depression, headache, and chronic pain syndromes. Anti-inflammatory and immunomodulating effects after transdermal vagal stimulation raised interest for applications in other diseases. Patients with sympathetic overactivity, reduced cardiac vagal drive and presence of systemic inflammation like POTS may benefit from tVNS. This article will address crucial methodological aspects of tVNS and provide preliminary results of its acute and chronic use in POTS, with regards to its potential effectiveness on autonomic symptoms reduction and heart rate modulation.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autonomic function; Postural tachycardia syndrome; Vagal stimulation

Mesh:

Year:  2021        PMID: 34634682      PMCID: PMC8939715          DOI: 10.1016/j.autneu.2021.102886

Source DB:  PubMed          Journal:  Auton Neurosci        ISSN: 1566-0702            Impact factor:   3.145


  85 in total

Review 1.  The antidepressant mechanism of action of vagus nerve stimulation: Evidence from preclinical studies.

Authors:  Annelies Grimonprez; Robrecht Raedt; Chris Baeken; Paul Boon; Kristl Vonck
Journal:  Neurosci Biobehav Rev       Date:  2015-06-25       Impact factor: 8.989

2.  Reversible Sensorineural Hearing Loss Associated with Off-Label Use of Transcutaneous Vagal Nerve Stimulator.

Authors:  Samuel Early; Konstantina M Stankovic
Journal:  Otolaryngol Head Neck Surg       Date:  2018-10       Impact factor: 3.497

3.  Vagal neurostimulation in patients with coronary artery disease.

Authors:  A V Zamotrinsky; B Kondratiev; J W de Jong
Journal:  Auton Neurosci       Date:  2001-04-12       Impact factor: 3.145

4.  Neurophysiologic effects of transcutaneous auricular vagus nerve stimulation (taVNS) via electrical stimulation of the tragus: A concurrent taVNS/fMRI study and review.

Authors:  Bashar W Badran; Logan T Dowdle; Oliver J Mithoefer; Nicholas T LaBate; James Coatsworth; Joshua C Brown; William H DeVries; Christopher W Austelle; Lisa M McTeague; Mark S George
Journal:  Brain Stimul       Date:  2017-12-29       Impact factor: 8.955

5.  Sympathetic overactivity in active ulcerative colitis: effects of clonidine.

Authors:  Raffaello Furlan; Sandro Ardizzone; Laura Palazzolo; Alexandra Rimoldi; Francesca Perego; Franca Barbic; Maurizio Bevilacqua; Luca Vago; Gabriele Bianchi Porro; Alberto Malliani
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2005-08-25       Impact factor: 3.619

6.  Vagal and Sympathetic Function in Neuropathic Postural Tachycardia Syndrome.

Authors:  Giris Jacob; Laura Diedrich; Kyoko Sato; Robert J Brychta; Satish R Raj; David Robertson; Italo Biaggioni; André Diedrich
Journal:  Hypertension       Date:  2019-05       Impact factor: 10.190

7.  Auricular transcutaneous electrical nerve stimulation in depressed patients: a randomized controlled pilot study.

Authors:  Ernst Hein; Magdalena Nowak; Olga Kiess; Teresa Biermann; Kristina Bayerlein; Johannes Kornhuber; Thomas Kraus
Journal:  J Neural Transm (Vienna)       Date:  2012-11-02       Impact factor: 3.575

8.  Transcutaneous auricular vagus nerve stimulation reduces pain and fatigue in patients with systemic lupus erythematosus: a randomised, double-blind, sham-controlled pilot trial.

Authors:  Cynthia Aranow; Yemil Atish-Fregoso; Martin Lesser; Meggan Mackay; Erik Anderson; Sangeeta Chavan; Theodoros P Zanos; Timir Datta-Chaudhuri; Chad Bouton; Kevin J Tracey; Betty Diamond
Journal:  Ann Rheum Dis       Date:  2020-11-03       Impact factor: 19.103

9.  Auricular acupuncture and vagal regulation.

Authors:  Wei He; Xiaoyu Wang; Hong Shi; Hongyan Shang; Liang Li; Xianghong Jing; Bing Zhu
Journal:  Evid Based Complement Alternat Med       Date:  2012-11-27       Impact factor: 2.629

10.  Transcutaneous vagus nerve stimulation for the treatment of depression: a study protocol for a double blinded randomized clinical trial.

Authors:  Pei-Jing Rong; Ji-Liang Fang; Li-Ping Wang; Hong Meng; Jun Liu; Ying-ge Ma; Hui Ben; Liang Li; Ru-Peng Liu; Zhan-Xia Huang; Yu-Feng Zhao; Xia Li; Bing Zhu; Jian Kong
Journal:  BMC Complement Altern Med       Date:  2012-12-14       Impact factor: 3.659

View more
  2 in total

Review 1.  Sympathetic and Vagal Nerve Activity in COPD: Pathophysiology, Presumed Determinants and Underappreciated Therapeutic Potential.

Authors:  Jens Spiesshoefer; Binaya Regmi; Matteo Maria Ottaviani; Florian Kahles; Alberto Giannoni; Chiara Borrelli; Claudio Passino; Vaughan Macefield; Michael Dreher
Journal:  Front Physiol       Date:  2022-06-23       Impact factor: 4.755

2.  Brain fog in neuropathic postural tachycardia syndrome may be associated with autonomic hyperarousal and improves after water drinking.

Authors:  Belén Rodriguez; Annie Hochstrasser; Philippe J Eugster; Eric Grouzmann; René M Müri; Werner J Z'Graggen
Journal:  Front Neurosci       Date:  2022-08-05       Impact factor: 5.152

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.